Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 39.45 TWD -1.62%
Market Cap: NT$3.5B

Maxigen Biotech Inc
PP&E Gross

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Maxigen Biotech Inc
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Grape King Bio Ltd
TWSE:1707
PP&E Gross
NT$8.1B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
4%
Maywufa Co Ltd
TWSE:1731
PP&E Gross
NT$1.2B
CAGR 3-Years
18%
CAGR 5-Years
17%
CAGR 10-Years
8%
Chlitina Holding Ltd
TWSE:4137
PP&E Gross
NT$2.1B
CAGR 3-Years
9%
CAGR 5-Years
2%
CAGR 10-Years
7%
No Stocks Found

Maxigen Biotech Inc
Glance View

Market Cap
3.5B TWD
Industry
Consumer products

Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2011-05-18. The firm operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.

Intrinsic Value
36.12 TWD
Overvaluation 8%
Intrinsic Value
Price NT$39.45

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett